Pharmaceutical drug opportunity assessment
Our insights and recommendations will give you the confidence to make the right strategic decisions at the early stages of commercialisation
Product development is the lifeblood of the pharmaceutical industry. But evaluating the wealth of potential opportunities at the early stages of drug discovery and commercialisation is fraught with uncertainty. We can help you to assess and evaluate opportunities systematically and comprehensively, using a range of qualitative research and quantitative research methods to answer questions such as:
- Where are the unmet needs in the marketplace?
- What is the viability of this product concept?
- What is the size of the market opportunity?
- What is the likely demand for this product?
- Where are the growth markets?
- What is the competitive landscape?
- What should our portfolio look like?
Custom research offerings include:
- Market access consulting
- Demand assessments and forecasting
- Concept evaluations
- Market and product analysis
- Portfolio planning
- Competitor analysis
- How we used a hybrid qual-quant methodology to assess the market opportunity for a new rare disease treatment
The challenge: Our client is a recently established independent biopharmaceutical company specialising in small molecule development. They were developing a new oral compound for the treatment of a rare genetic disease for which the standard treatment is administered intravenously, however a large proportion of patients receive monitoring only or remain undiagnosed. Their objective was to successfully launch their product in order to provide clinically meaningful…read more »How we assessed the access potential of a new product in order to develop a successful launch strategy
Our client had two regimens in clinical development for the front-line treatment of an oncology condition using a breakthrough product; and planned to release outcomes data at key industry events throughout the year.read more »Using demand assessment techniques to evaluate the market landscape and product opportunity
The challenge:Our client wanted to evaluate the potential of two treatments which would offer efficacy and side effects similar to those of biologics in atopic dermatitis. Therefore our client needed to understand more about the US and German market landscape in moderate-severe atopic dermatitis and how these advanced treatments might fit into the treatment algorithim when they are launched, as well as the potential drivers…read more »How the opportunity for a product treating a rare haematology disease in Emerging Markets was evaluated using a multi-stakeholder approach
Our client wanted to determine how to maximise the commercial opportunities for a product indicated for a rare disease in a range of emerging marketsread more »
- Some example case studiesHow an online market research community delivered fresh insights into a small and hard-to-reach audience
Often a short research study isn’t sufficient to get the level of insights and understanding that you require, especially when working with a hard to reach target audience.read more »How we helped determine the next groundbreaking development in a hard-to-treat respiratory disease
The challengeOur client wanted to understand the current management in a complex therapy area, as treatment regimens require a combination of multiple drugs. Furthermore, the disease is most prevalent in emerging, hard-to-access markets. Understanding of drugs and treatment regimen preferences were required to help gauge likely success of the client’s new formulation in development, which would be part of a new regimen paradigm. As well…read more »How we used WhatsApp and projective exercises to capture deep emotional insights into people living with HIV in South Africa
The challengeOur client wanted to identify and profile different segments of people living with HIV in order to understand key barriers and leverage points and ensure future engagement with their pharmaceutical portfolio. To achieve this, we needed to conduct an in-depth exploration of attitudes and behaviours of people living with HIV. However, stigma surrounding HIV in South Africa meant that respondents may have been unwilling…read more »